U.S. Pharma Stock News

Recent commentary on Ellington Financial (EFC) focuses on how its hedging, diversified portfolio, financing sources, and relatively low leverage are helping it manage mortgage market volatility and ongoing loan origination activity. See our latest analysis for Ellington Financial. At a share price of US$11.55, Ellington Financial has seen a 2.21% 7 day share price gain, but its 30 day and year to date share price returns of 7.75% and 15.57% declines suggest momentum has cooled, even as the 3...

Microsoft (MSFT) is experiencing its sharpest correction in years after ramping up AI infrastructure spending and pausing hiring in key cloud and sales units, even as its cloud and AI businesses continue to perform strongly. See our latest analysis for Microsoft. Microsoft’s share price has fallen 24.6% year to date and about 26.9% over three months, with a 10.9% 30 day share price decline. Recent AI capex headlines and hiring pauses have reinforced a sense that momentum is fading, despite...

AnaptysBio (ANAB) has drawn attention after its recent share performance, with the stock showing negative returns over the past week, alongside positive moves over the past month and past 3 months. See our latest analysis for AnaptysBio. At a share price of $57.40, AnaptysBio has seen a sharp 11.68% one day share price decline and a 7.96% 7 day share price pullback. However, its 27.70% year to date share price return and 1 year total shareholder return of 202.90% indicate that longer term...

Why WeRide Stock Is on Investor Radars Now WeRide (WRD) has drawn fresh attention after recent trading moves, with the share price closing at US$6.96 and short term returns swinging between gains over the past week and declines over the month and past 3 months. See our latest analysis for WeRide. Recent trading has been choppy, with a 1 day share price return of 9% decline, a 7 day share price return of 9.53% gain, and a year to date share price return of 25.93% decline, while the 1 year...

Western Digital (WDC) came under pressure after Google introduced its TurboQuant compression algorithm, a tool designed to cut memory usage for large AI models and prompting investors to reassess demand for memory hardware. See our latest analysis for Western Digital. The recent pullback around Google’s TurboQuant news comes after a strong run, with Western Digital’s 90 day share price return of 51.67% and a very large 1 year total shareholder return. Shorter term momentum looks choppy, while...

Federal court certifies a class-action lawsuit against NasdaqGS:NVDA over alleged misrepresentation of gaming GPU revenue tied to cryptocurrency mining in 2017 to 2018. The certified class covers investors who bought Nvidia stock between August 2017 and November 2018. The case moves closer to trial after the Supreme Court declined to hear Nvidia’s appeal, following earlier SEC enforcement action related to similar disclosures. Nvidia, traded as NasdaqGS:NVDA, is best known for graphics...

Republic Services (RSG) is back in focus after recent commentary highlighted a slowdown in demand, with annualized revenue growth of 5.3% over the past two years trailing its five year trend. See our latest analysis for Republic Services. Recent trading reflects that cooling demand story, with a 30 day share price return of a 2.6% decline and a 1 year total shareholder return of an 8.6% decline. This contrasts with a much stronger 5 year total shareholder return of 130.1% and suggests that...

Stock performance snapshot and recent context United Community Banks (UCB) stock has seen mixed recent performance, with a 1 day return of about a 1.3% decline, a 7 day gain of 2.7%, and a month return of an 8.1% decline as of the latest close. See our latest analysis for United Community Banks. At around $30.93 per share, the recent 8.1% 30 day share price decline contrasts with a 14.9% 1 year total shareholder return. This suggests shorter term caution, while longer term investors have...

Investors may be wondering whether Materion, at around US$141 a share, still offers value or if most of the potential upside has already been priced in. The stock has moved sharply, with a 7.1% gain over the last week, a 12.5% decline over the last month, and returns of 10.0% year to date and 70.4% over the past year. These swings have kept the stock on many investors' watchlists, as price action alone does not explain what is driving sentiment. Recent coverage has focused on how the...

In March 2026, Kingsoft Cloud Holdings reported record fourth-quarter and full-year 2025 revenue of CNY 2,761.39 million and CNY 9,558.62 million respectively, alongside narrower net losses, board and committee leadership changes, and proposed amendments to its articles of association to enable virtual shareholder meetings and align with Hong Kong Listing Rules. A key highlight was very large AI business gross billing growth, with AI-related services contributing nearly half of public cloud...

If you are wondering whether Plains GP Holdings at around US$24.46 still offers value or if most of the opportunity is already priced in, the starting point is to look closely at what the market is paying for its fundamentals. The stock has delivered returns of 3.3% over the past week, 10.2% over the last month, 26.0% year to date and 23.4% over the past year, with a very large 3 year gain and a 272.0% return over 5 years that may shape current expectations and risk views. Recent headlines...

Pentair (NYSE:PNR) announced the retirement of long-serving Chair David A. Jones after more than two decades on the Board and eight years as Chair. T. Michael Glenn, an independent director with extensive board experience, has been appointed as the new Chair. The transition marks a planned change in board leadership and governance oversight at Pentair. Pentair focuses on water treatment and fluid management solutions, an area that sits at the intersection of infrastructure, sustainability...

Graco recently reported a past quarter with revenues up 8.1% year on year and earnings exceeding analysts’ EBITDA expectations, reflecting solid near‑term execution. However, flat sales over the last two years, declining earnings per share, and shrinking returns on capital have raised concerns about longer‑term growth and profitability. We’ll now explore how these signs of muted long‑term growth, despite a recent earnings beat, may influence Graco’s broader investment narrative. Outshine the...

Why Donaldson Company (DCI) is on investors’ radar today Recent performance in Donaldson Company (DCI) shares, including a roughly 20% decline over the past month and an 8% decline over the past 3 months, has drawn fresh investor attention. With the stock last closing at US$83.87 and a market value of about US$9.8b, investors are weighing how the filtration specialist’s current valuation compares with its business mix and profitability. See our latest analysis for Donaldson Company. The...

Earlier this week, a Los Angeles jury ruled that Alphabet’s Google and Meta designed YouTube and Instagram in ways that contributed to a young woman’s social media addiction and mental health harms, awarding a combined US$6.00 million in compensatory and punitive damages and finding both companies failed to adequately warn users about these risks. This verdict targets the core design of engagement-driving features rather than user content, potentially reshaping legal protections under...

Earlier in 2026, Zimmer Biomet was honored with three Healthcare Asia Medtech Awards for its iodine-treated hip implants, WalkAI recovery platform, and surgeon engagement initiatives, underscoring its focus on orthopedic and digital health innovation. The recognition for WalkAI, which applies artificial intelligence to monitor knee replacement recovery and enable earlier clinical intervention, highlights how Zimmer Biomet is pairing traditional implants with data-driven tools to support...

AbbVie (NYSE:ABBV) is presenting new clinical research across its dermatology portfolio at the 2026 American Academy of Dermatology Annual Meeting. The company is showcasing data on treatment outcomes for immune mediated skin diseases, including late breaking Phase 3 results in vitiligo and alopecia areata. The presentations feature durable long term outcomes, quality of life measures, and investigational results for new indications. For investors, this update highlights how AbbVie is...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

On March 17, 2026, Universal Technical Institute Director George W. Brochick disclosed an indirect sale of 5,000 shares in an SEC Form 4 filing, while the company continued to benefit from solid operating performance and a new multi-year equipment agreement with Fuji Spray Auto for student training. An interesting angle is that Brochick’s sale appears routine given his remaining holdings, keeping investor attention on Universal Technical Institute’s operational progress and its expanded...

In the past year, Linde has continued to outperform the specialty chemicals industry, driven by consistent profit growth, disciplined capital allocation, and high operational efficiency across its global industrial gases portfolio. A key insight is that Linde’s robust, contract-backed project pipeline, combined with cost controls and automation, appears to be reinforcing its margins and operational resilience, even as peers face a more mixed backdrop. We’ll now examine how Linde’s ongoing...

Earlier this week, McCormick expanded its 2026 Flavor of the Year campaign by rolling out Black Currant seasoning and finishing sugar, and by hosting Sensoria: The Black Currant Experience in New York, a multisensory event that brought the flavor trend to consumers and culinary professionals. This push around Black Currant underlines how McCormick uses trend-driven product innovation and immersive brand experiences to deepen engagement with both home cooks and foodservice partners. Next,...

For readers wondering whether Lockheed Martin at around US$615 per share still offers value, or if most of the easy gains are behind it, this article walks through what the current price may be implying. The stock has given investors a 23.9% return year to date and 43.3% over the last year, with a 90.0% return across five years. However, the past 7 days and 30 days show declines of 1.8% and 4.9% respectively. Recent headlines have focused on Lockheed Martin's role in global defense programs...

On 24 March 2026, Medtronic announced a distribution agreement with Merit Medical Systems to offer ViaVerte, an FDA-cleared, minimally invasive basivertebral nerve ablation system for chronic vertebrogenic lower back pain, extending an existing supply relationship between the two companies. This agreement gives Merit access to Medtronic’s broad pain management distribution network, potentially increasing physician adoption of ViaVerte and reinforcing Merit's position in outpatient spine...

In March 2026, Genesis Energy and a current board member were sued in Harris County State Court for alleged repeated sexual assaults against a Jane Doe, with the complaint seeking US$50,000,000 in compensatory and punitive damages. The involvement of a sitting director and high-profile litigator Tony Buzbee, known for very large sexual assault outcomes, raises important questions about Genesis Energy’s governance and reputational risk controls. Against this backdrop, we’ll explore how the...